BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11739404)

  • 1. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.
    Ye Q; Hu YF; Zhong H; Nye AC; Belmont AS; Li R
    J Cell Biol; 2001 Dec; 155(6):911-21. PubMed ID: 11739404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies of mutations in BRCA1 transactivation domain by visualization of chromatin structure].
    Ye QN; Hu YF; Zhong HJ; Li R; Huang CF
    Yi Chuan Xue Bao; 2002; 29(11):941-8. PubMed ID: 12645254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mapping of BRCT1 domain of BRCA1 with chromatin unfolding activity].
    Ye QN; Hu YF; Zhong HJ; Li R; Huang CF
    Sheng Wu Gong Cheng Xue Bao; 2002 Nov; 18(6):656-61. PubMed ID: 12674632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional comparison of BRCA1 C-terminal domains in transcription activation and chromatin remodeling.
    Miyake T; Hu YF; Yu DS; Li R
    J Biol Chem; 2000 Dec; 275(51):40169-73. PubMed ID: 11016938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1.
    Chen GC; Guan LS; Yu JH; Li GC; Choi Kim HR; Wang ZY
    Biochem Biophys Res Commun; 2001 Jun; 284(2):507-14. PubMed ID: 11394910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity.
    Sum EY; Peng B; Yu X; Chen J; Byrne J; Lindeman GJ; Visvader JE
    J Biol Chem; 2002 Mar; 277(10):7849-56. PubMed ID: 11751867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 interacts with FHL2 and enhances FHL2 transactivation function.
    Yan J; Zhu J; Zhong H; Lu Q; Huang C; Ye Q
    FEBS Lett; 2003 Oct; 553(1-2):183-9. PubMed ID: 14550570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
    Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
    Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.
    Bochar DA; Wang L; Beniya H; Kinev A; Xue Y; Lane WS; Wang W; Kashanchi F; Shiekhattar R
    Cell; 2000 Jul; 102(2):257-65. PubMed ID: 10943845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
    Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
    Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS; Green R; Glover JN
    Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pescadillo induces large-scale chromatin unfolding.
    Zhang H; Fang Y; Huang C; Yang X; Ye Q
    Sci China C Life Sci; 2005 Jun; 48(3):270-6. PubMed ID: 16092760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
    Drikos I; Nounesis G; Vorgias CE
    Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.
    Varma AK; Brown RS; Birrane G; Ladias JA
    Biochemistry; 2005 Aug; 44(33):10941-6. PubMed ID: 16101277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale chromatin unfolding and remodeling induced by VP16 acidic activation domain.
    Tumbar T; Sudlow G; Belmont AS
    J Cell Biol; 1999 Jun; 145(7):1341-54. PubMed ID: 10385516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
    Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G
    Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.
    Hayes F; Cayanan C; BarillĂ  D; Monteiro AN
    Cancer Res; 2000 May; 60(9):2411-8. PubMed ID: 10811118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the BRCT domains of the breast cancer susceptibility gene product BRCA1.
    Ekblad CM; Wilkinson HR; Schymkowitz JW; Rousseau F; Freund SM; Itzhaki LS
    J Mol Biol; 2002 Jul; 320(3):431-42. PubMed ID: 12096901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of large-scale chromatin unfolding by Smad4.
    Yan J; Fang Y; Ding L; Zhu J; Lu Q; Huang C; Yang X; Ye Q
    Biochem Biophys Res Commun; 2004 Mar; 315(2):330-5. PubMed ID: 14766211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer predisposing mutations in BRCT domains.
    di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
    IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.